Home | Small-molecule inhibitors of GRHL transcription factors for use in cancer treatment, especially colorectal cancer
Therapies
Small-molecule inhibitors of GRHL transcription factors for use in cancer treatment, especially colorectal cancer
Patent inventors: Tomasz Wilanowski, Adam Jarmuła, Piotr Maj, Katarzyna Wiktorska, Anna Pogorzelska
A description of the invention will be available after the patent application is published.
Nencki Institute is the co-applicant with University of Warsaw and National Medicines Institutes. University of Warsaw is the leader in patent protection and commercialization-related activities.
For more information contact Technology Transfer Office.
Application number:
P.442297 (15.09.2022)
Patent status:
pending